Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India

Indian Journal of Medical Research

Volumn 121, Issue 4, 2005, Pages 235-239

  Pereira, Mycal ^b   Tripathy, Srikanth ^b   Inamdar, Vikas ^a   Ramesh, K ^b   Bhavsar, Manoj ^a   Date, Amruta ^a   Iyyer, Rajshekar ^a   Acchammachary, Anand ^b   Mehendale, Sanjay ^b   Risbud, Arun ^b  

^a Pimpri Chinchwad Municipal Corporation   (India)

^b NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

BACTEC MGIT 960; Drug resistance; HIV; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANAMNESIS; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; QUANTITATIVE ANALYSIS; SERODIAGNOSIS; SPUTUM ANALYSIS; TEMPERATURE MEASUREMENT;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; INDIA; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 21044437487     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Raviglione MC, Dye C, Schmidt S, Kochi A. WHO global surveillance and monitoring project. Assessment of worldwide tuberculosis control. Lancet 1997; 350 : 624-9.
2. Baptista IMFD, Oelemann MC, Opromolla DVA, Suffys PA. Drug resistance and genotypes of strains of Mycobacterium tuberculosis isolated from human immunodeficiency virus-infected and non-infected tuberculosis patients in Bauru, São Paulo, Brazil. Mem Inst Oswaldo Cruz 2002; 97: 1147-52.
3. Paranjape RS, Tripathy SP, Menon PA, Mehendale SM, Khatavkar P, Joshi DR, et al. Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India. Indian J Med Res 1997; 106 : 207-11.
4. Tripathy S, Joshi DR, Mehendale SM, Menon P, Joshi AN, Ghorpade SV, et al. Sentinel surveillance for HIV infection tuberculosis patients in India. Indian J Tuberc 2002; 49 : 17-20.
5. World Health Organization. Anti tuberculosis drug resistance in the world. The WHO/WATLD global project on anti-tuberculosis surveillance. Geneva, Switzerland; 1997. WHO/TB/97. 229.
6. Anti tuberculosis drug resistance in the world, Report No. 2. WHO/CDS/TB/2000. 278.
7. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for anti-tuberculosis drug resistance 1994-97. N Engl J Med 1998; 338 : 1641-9.
8. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to anti-tuberculosis drugs. N Engl J Med 2001; 344 : 1294-303.
9. Laboratory Services in tuberculosis control. Part III-Culture/WHO/98.258, 1998. http://www.who.int/docstore/gtb/publications/whodoc/whotb-98-258/en/ 98.258/culture-3.pdf.
10. Kent PT, Kubica GP. Public Health Mycobacteriology. A Guide for the Level III Laboratory. Atlanta: U.S. Department of Health and Human Services, Public Health Service, CDC, 1985.
11. Tortoli E, Benedetti M, Fontanelli A, Simonetti T. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: Comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol 2002; 40 : 607-10.
12. Ardito F, Posteraro B, Sanguinetti M, Zanetti S, Fadda G. Evaluation of BACTEC Mycobacteria growth indicator tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2001; 39: 4440-4.
13. Paramasivan CN. An overview of drug resistant tuberculosis in India. Lung India 1998; 15 : 21-8.
14. Gordin FM, Nelson ET, Matts JP, Cohn DL, Ernst J, Benator D, et al. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med 1996; 154 : 1478-83.
15. Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Scarparo C, et al. Mycobacterium tuberculosis complex drug resistance in Italy. Emerg Infect Dis 2004; 10 : 752-3.
16. Shafer RW, Chirgwin KD, Glatt AE, Dahdouh MA, Landesman SH, Suster B. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991; 5 : 399-405.
17. Asch S, Knowles L, Rai A, Jones BE, Pogoda J, Barnes PF. Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med 1996; 153 : 1708-10.
18. Spellman CW, Matty KJ, Weis SE. A survey of drug-resistant Mycobacterium tuberculosis and its relationship to HIV infection. AIDS 1998; 12 : 191-5.